Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Bahram Valamehr

CEO, President at Fate Therapeutics Inc (FATE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $168K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 5SEC FATEFate Therapeutics Inc Sell 43,947591,815 held (−7%) $2.46 $108K -27.2%
May 21SEC FATEFate Therapeutics Inc Sell 28,946635,762 held (−4%) $1.88 $54K -4.8%
Jan 12SEC FATEFate Therapeutics Inc Sell 5,190329,708 held (−2%) $1.07 $6K +67.3%